<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Subclassification of malignant non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is important to be able to choose the right treatment </plain></SENT>
<SENT sid="1" pm="."><plain>However, this subclassification can be difficult, and immunohistochemistry and polymerase chain reaction are used to improve diagnostic safety </plain></SENT>
<SENT sid="2" pm="."><plain>We have investigated the value of immunohistochemistry and polymerase chain reaction in the subclassification of 49 low grade non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of B-cell type </plain></SENT>
<SENT sid="3" pm="."><plain>Immunohistochemistry showed B-<z:mp ids='MP_0005384'>cell phenotype</z:mp> in <z:hpo ids='HP_0000001'>all</z:hpo> biopsies, and 23 (85%) of 27 follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> showed positive reaction for bcl-2 antibodies in follicles </plain></SENT>
<SENT sid="4" pm="."><plain>Polymerase chain reaction demonstrated a monoclonal pattern for IgH in 36 (73%) of 49 biopsies, and 10 (37%) of 27 follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> demonstrated translocation (14; 18) </plain></SENT>
<SENT sid="5" pm="."><plain>Immunohistochemistry and polymerase chain reaction contributed to subclassification or confirmation of the diagnosis of 46 (94%) of 49 biopsies </plain></SENT>
<SENT sid="6" pm="."><plain>Our conclusion is that immunohistochemistry and polymerase chain reaction have a natural place in the diagnosis of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>